Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- MEDICAL DEVICE NEWS IN BRIEF
December 16, 2002
- Nissan Chemical: Drug Sales Down 31.4% to \718 Mil.
December 16, 2002
- PhRMA Issues Program for 21st Century Health Reform in Japan
December 9, 2002
- Atol: Net Profits Down 16.3% Despite Higher Sales
December 9, 2002
- NanoCarrier, Kirin to Collaborate on Novel Anticancer Agents
December 9, 2002
- Bayer AG Actively Seeking Alliance: Mr Wenning
December 9, 2002
- Astis: Sales Up 0.9% to \44.7 Bil.
December 9, 2002
- RESEARCH & DEVELOPMENT NEWS IN BRIEF
December 9, 2002
- Sankyo to Spin Off Agricultural Chemicals, Specialty Products
December 9, 2002
- Seiwa Sangyo: 4.5% Increase in Sales Boosts Profits
December 9, 2002
- Kobayashi Pharma: New Products, Cost-cutting Boost Sales and Profits
December 9, 2002
- BUSINESS NEWS IN BRIEF
December 9, 2002
- Sales of Tacrolimus to Reach \100 Bil. Worldwide: Dr Aoki of Fujisawa
December 9, 2002
- OTC NEWS IN BRIEF
December 9, 2002
- Amarin Targets Major Drug Companies in Japan: Mr Downie
December 9, 2002
- Sanki: Net Profits Up 42.4% with 3.1% Rise in Sales
December 9, 2002
- DIAGNOSTIC NEWS IN BRIEF
December 9, 2002
- 27 Listed Drug Firms: Sales Up 4.1%, Net Profits Down 8.4%
December 9, 2002
- Ohki: Profits Leap with 8.6% Rise in Sales
December 9, 2002
- MEDICAL DEVICE NEWS IN BRIEF
December 9, 2002
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…